Display options
Cite
Mallol J, Solé D, Garcia-Marcos L, et al. Prevalence, Severity, and Treatment of Recurrent Wheezing During the First Year of Life: A Cross-Sectional Study of 12,405 Latin American Infants. Allergy Asthma Immunol Res. 2015;8(1):22-31doi: 10.4168/aair.2016.8.1.22.
Mallol, J., Solé, D., Garcia-Marcos, L., Rosario, N., Aguirre, V., Chong, H., Urrutia-Pereira, M., Szulman, G., Niederbacher, J., Arruda-Chavez, E., Toledo, E., Sánchez, L., Pinchak, C. (2016). Prevalence, Severity, and Treatment of Recurrent Wheezing During the First Year of Life: A Cross-Sectional Study of 12,405 Latin American Infants. Allergy, asthma & immunology research, 8(1), 22-31. https://doi.org/10.4168/aair.2016.8.1.22
Mallol, Javier, et al. "Prevalence, Severity, and Treatment of Recurrent Wheezing During the First Year of Life: A Cross-Sectional Study of 12,405 Latin American Infants." Allergy, asthma & immunology research vol. 8,1 (2016): 22-31. doi: https://doi.org/10.4168/aair.2016.8.1.22
Mallol J, Solé D, Garcia-Marcos L, Rosario N, Aguirre V, Chong H, Urrutia-Pereira M, Szulman G, Niederbacher J, Arruda-Chavez E, Toledo E, Sánchez L, Pinchak C. Prevalence, Severity, and Treatment of Recurrent Wheezing During the First Year of Life: A Cross-Sectional Study of 12,405 Latin American Infants. Allergy Asthma Immunol Res. 2016 Jan;8(1):22-31. doi: 10.4168/aair.2016.8.1.22. Epub 2015 Jul 27. PMID: 26540498; PMCID: PMC4695404.
Copy Download .nbib Format: NLM
Share it on

Allergy Asthma Immunol Res. 2016 Jan;8(1):22-31. doi: 10.4168/aair.2016.8.1.22. Epub 2015 Jul 27.

Prevalence, Severity, and Treatment of Recurrent Wheezing During the First Year of Life: A Cross-Sectional Study of 12,405 Latin American Infants.

Allergy, asthma & immunology research

Javier Mallol, Dirceu Solé, Luis Garcia-Marcos, Nelson Rosario, Viviana Aguirre, Herberto Chong, Marilyn Urrutia-Pereira, Gabriela Szulman, Jurg Niederbacher, Erika Arruda-Chavez, Eliana Toledo, Lillian Sánchez, Catalina Pinchak,

Affiliations

  1. Department of Pediatric Respiratory Medicine, Hospital El Pino, University of Santiago de Chile (USACH), Santiago, Chile. [email protected].
  2. Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
  3. Pediatric Respiratory and Allergy Units, "Virgen de la Arrixaca" University Children's Hospital, University of Murcia, and IMIB Research Institute, Murcia, Spain.
  4. Department of Pediatrics, Hospital de Clínicas, Federal University of Paraná (UFPR), Curitiba, Brazil.
  5. Department of Pediatric Respiratory Medicine, Hospital El Pino, University of Santiago de Chile (USACH), Santiago, Chile.
  6. Pediatric Asthma Prevention Program (PIPA), Uruguaiana, Brazil.
  7. Hospital de Niños "Ricardo Gutierréz", Buenos Aires, Argentina.
  8. Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia.
  9. Section of Allergy and Clinical Immunology, British American Hospital, Lima, Peru.
  10. Hospital de Base de São José do Rio Preto, Faculty of Medicine of Sao José do Rio Preto, São Paulo, Brazil.
  11. Department of Pediatrics, Federal University of Mato Grosso, Cuiaba, Brazil.
  12. Clínica Pediátrica "B". Hospital Pereira Rossell, Facultad Medicina, Universidad de la Republica, Montevideo, Uruguay.

PMID: 26540498 PMCID: PMC4695404 DOI: 10.4168/aair.2016.8.1.22

Abstract

PURPOSE: This study aimed to determine the prevalence and severity of recurrent wheezing (RW) defined as ≥3 episodes of wheezing, risk factors, and treatments prescribed during the first year of life in Latin American infants.

METHODS: In this international, cross-sectional, and community-based study, parents of 12,405 infants from 11 centers in 6 South American countries (Argentina, Brazil, Chile, Colombia, Peru, and Uruguay) completed a questionnaire about wheezing and associated risk/protective factors, asthma medications, and the frequency of and indications for the prescription of antibiotics and paracetamol during the first year of life.

RESULTS: The prevalence of RW was 16.6% (95% CI 16.0-17.3); of the 12,405 infants, 72.7% (95% CI 70.7-74.6) visited the Emergency Department for wheezing, and 29.7% (27.7-31.7) was admitted. Regarding treatment, 49.1% of RW infants received inhaled corticosteroids, 55.7% oral corticosteroids, 26.3% antileukotrienes, 22.9% antibiotics ≥4 times mainly for common colds, wheezing, and pharyngitis, and 57.5% paracetamol ≥4 times. Tobacco smoking during pregnancy, household income per month <1,000 USD, history of parental asthma, male gender, and nursery school attendance were significant risk factors for higher prevalence and severity of RW, whereas breast-feeding for at least 3 months was a significant protective factor. Pneumonia and admissions for pneumonia were significantly higher in infants with RW as compared to the whole sample (3.5-fold and 3.7-fold, respectively).

CONCLUSIONS: RW affects 1.6 out of 10 infants during the first year of life, with a high prevalence of severe episodes, frequent visits to the Emergency Department, and frequent admissions for wheezing. Besides the elevated prescription of asthma medications, there is an excessive use of antibiotics and paracetamol in infants with RW and also in the whole sample, which is mainly related to common colds.

Keywords: Asthma; antibiotics; epidemiology; prevalence; recurrent wheezing; respiratory sounds

References

  1. Pediatr Allergy Immunol. 2010 Aug;21(5):878-88 - PubMed
  2. Thorax. 2010 Nov;65(11):1004-9 - PubMed
  3. Clin Exp Allergy. 2005 Jan;35(1):18-25 - PubMed
  4. Pediatr Allergy Immunol. 2014 Mar;25(2):201-3 - PubMed
  5. Clin Exp Allergy. 2007 Dec;37(12):1738-46 - PubMed
  6. JAMA. 1998 Mar 18;279(11):875-7 - PubMed
  7. Lancet. 2008 Sep 20;372(9643):1039-48 - PubMed
  8. Int Arch Allergy Immunol. 2007;144(1):44-50 - PubMed
  9. BMC Pharmacol Toxicol. 2014 Aug 09;15:44 - PubMed
  10. J Allergy Clin Immunol. 2013 Jun;131(6):1518-25 - PubMed
  11. J Allergy Clin Immunol. 2014 Sep;134(3):728-9 - PubMed
  12. Am J Public Health. 1992 Aug;82(8):1119-26 - PubMed
  13. J Investig Allergol Clin Immunol. 2009;19(1):35-42 - PubMed
  14. CMAJ. 2007 Oct 9;177(8):877-83 - PubMed
  15. Pediatr Allergy Immunol. 2007 Feb;18(1):86-7 - PubMed
  16. J Spec Pediatr Nurs. 2014 Jul;19(3):266-9 - PubMed
  17. Ther Adv Infect Dis. 2013 Aug;1(4):139-50 - PubMed
  18. Pediatrics. 2011 Jun;127(6):1174-6 - PubMed
  19. Eur J Public Health. 2013 Aug;23(4):706-10 - PubMed
  20. Eur Respir J. 2011 Aug;38(2):295-302 - PubMed
  21. Eur J Clin Pharmacol. 2013 Jun;69(6):1197-209 - PubMed
  22. J Allergy Clin Immunol. 2009 Nov;124(5):982-9 - PubMed
  23. Pediatrics. 2011 Dec;128(6):1053-61 - PubMed
  24. Pediatrics. 2003 Jul;112(1 Pt 1):49-57 - PubMed
  25. Lancet. 2007 Nov 10;370(9599):1589 - PubMed
  26. Eur Respir J. 2013 Mar;41(3):664-70 - PubMed
  27. Arch Dis Child. 2007 Jul;92(7):594-7 - PubMed
  28. J Allergy Clin Immunol. 2010 Nov;126(5):1071-3 - PubMed
  29. Clin Exp Allergy. 2012 Jan;42(1):104-11 - PubMed
  30. Allergol Immunopathol (Madr). 2009 Sep-Oct;37(5):249-51 - PubMed
  31. Int J Epidemiol. 2008 Jun;37(3):583-90 - PubMed
  32. Allergol Immunopathol (Madr). 2010 Jul-Aug;38(4):203-12 - PubMed
  33. PLoS One. 2014 Apr 09;9(4):e93869 - PubMed
  34. BMJ. 2010 Sep 15;341:c4616 - PubMed
  35. Allergol Immunopathol (Madr). 2005 Sep-Oct;33(5):257-63 - PubMed

Publication Types